10.04.2026 • News

Syensqo and Shell Chemicals to Advance Low-Carbon Ethylene Oxide Solutions

Certified alternative ethylene oxide (EO)-based ingredients enable customers to reduce Scope 3 greenhouse gas emissions while maintaining high performance standards.

Syensqo and Shell Chemicals Europe have joined forces to supply mass-balanced, low-carbon EO solutions for the agricultural and industrial markets, enabling reduced product carbon footprint (PCF) without compromising performance.

Syensqo intends to introduce EO-based solutions made with Shell Chemicals’ lower-carbon feedstocks, which deliver up to 51% lower carbon footprint versus conventional EO1, enabled through the use of carbon capture utilization (CCU) credits via a mass-balance approach. 

Verified under the ISCC Carbon Footprint Certification (CFC), these drop-in solutions allow customers to reduce the carbon footprint of their formulations without requalification, while maintaining performance, quality, and supply reliability.

Researcher in laboratory
© Syensqo

Chloé Masselon, Sustainability Director at Syensqo, commented: "Customers are under increasing pressure to reduce the carbon footprint of their products without compromising performance or supply reliability. Combining certified low-carbon feedstocks with drop-in compatibility, these solutions offer a practical and immediate way to decarbonize formulations at scale while meeting evolving regulatory and market expectations."

This initiative supports Syensqo’s One Planet ambition to reduce Scope 3 GHG emissions in Focus 5 categories by 25% by 2030 compared to 2021 levels. It also demonstrates that reducing value chain emissions requires collaboration across the ecosystem, from raw material suppliers to ingredients providers to finished goods manufacturers.


Company

Logo:

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

most read